Russia's sovereign wealth fund said on Wednesday it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against Covid-19 once it receives regulatory approval. Clinical trials of the Russian vaccine in India are expected to follow, held jointly with the Indian firm. Both the trials and supply deal depends on domestic regulatory approval.
